Updates in the management of gout

Am J Med. 2007 Mar;120(3):221-4. doi: 10.1016/j.amjmed.2006.02.044.

Abstract

The majority of patients with gout are cared for by primary care physicians. Although both the physician and patient may easily recognize the acute arthritis of gout, errors in selecting the most appropriate medication and proper dose are common. The clinical stages of gout include asymptomatic hyperuricemia, intermittent gouty arthritis, and chronic tophaceous gout. Treatment of gout is usually considered after the first attack of arthritis, typically podagra. The aims of treatment are to alleviate the pain and inflammation associated with acute attacks, prevent future attacks, and decrease uric acid levels. Confusion frequently arises because certain medications such as colchicine may have dual purposes: to treat an acute attack and to suppress future attacks. The purpose of this management update is to provide practical advice about prescribing the proper medication considering both treatment goals and patient comorbidities.

Publication types

  • Review

MeSH terms

  • Acute Disease
  • Adrenal Cortex Hormones / therapeutic use*
  • Adult
  • Aged
  • Allopurinol / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Arthritis, Gouty / diagnosis
  • Arthritis, Gouty / drug therapy
  • Chronic Disease
  • Colchicine / therapeutic use
  • Drug Therapy, Combination
  • Family Practice / standards
  • Family Practice / trends
  • Female
  • Gout / diagnosis
  • Gout / drug therapy*
  • Gout Suppressants / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Pain Measurement
  • Prognosis
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome
  • Uric Acid / urine

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents, Non-Steroidal
  • Gout Suppressants
  • Uric Acid
  • Allopurinol
  • Colchicine